Serum IGF1 Is a Prognostic Marker for Resistance to Targeted Therapies and a Predictive Marker for Anti-IGF1 Receptor Therapy in Melanoma - Vigipallia

0 avis

Serum IGF1 Is a Prognostic Marker for Resistance to Targeted Therapies and a Predictive Marker for Anti-IGF1 Receptor Therapy in Melanoma

Archive ouverte

Castillo-Ferrer, Camila | Marguet, Théo | Vanwonterghem, Laetitia | Erbek, Sule | Chuffart, Florent | Mouret, Stéphane | Messai, Sabiha Trabelsi | Gauchez, Anne-Sophie | Coll, Jean-Luc | Charles, Julie | Hurbin, Amandine | Martel-Frachet, Véronique

Edité par CCSD ; Nature Publishing Group -

International audience. No abstract available

Langue: en

Indexation

Consulter en ligne

Consulter le document

Consulter le document

Consulter le document

Suggestions

Du même auteur

Serum IGF1 Is a Prognostic Marker for Resistance to Targeted Therapies and a Predictive Marker for Anti-IGF1 Receptor Therapy in Melanoma

Archive ouverte | Castillo-Ferrer, Camila | CCSD

International audience

Efficacy of olaparib combined with dabrafenib and trametinib for a patient with BRAF mutated and ATM deleted metastatic melanoma

Archive ouverte | Marguet, Theo | CCSD

International audience

Efficacy of olaparib combined with dabrafenib and trametinib for a patient with BRAF mutated and ATM deleted metastatic melanoma

Archive ouverte | Marguet, Theo | CCSD

International audience

Chargement des enrichissements...